Soft-Tissue Tumors (Lipoma, Sarcoma)
- Most soft-tissue lumps are benign, and the most common one is a lipoma — a quiet blob of ordinary fat.
- MRI is the workhorse: the single most useful trick is asking "does this follow fat on every sequence?"
- Pure, uniform fat that suppresses cleanly is reassuring. Fat with thick septa, nodules, or non-fatty enhancing chunks is the part that worries us.
- A sarcoma is the rare, malignant lump that looks aggressive: large, deep, heterogeneous, and not behaving like any normal tissue.
- The big management rule: when a soft-tissue mass might be a sarcoma, don't just hack it out — get it to a sarcoma center first, because a bad first surgery can cost a limb.
Somebody feels a lump. It's been there a while, it doesn't hurt, and now it's your job to say whether it's a harmless wad of fat or something that needs a surgeon, an oncologist, and a serious conversation. That's the whole game with soft-tissue tumors: separating the boring blobs (the vast majority) from the rare bad actor hiding in the crowd.
The good news is that MRI gives us a genuinely powerful question to ask, and most of the time the answer is "relax."
Start with the most common lump: the lipoma
A lipoma is the body's most unambitious tumor. It's just a blob of mature fat — the same stuff that's already all over you — that decided to bunch up into a soft, squishable lump. On exam it feels like a slippery marshmallow under the skin. On MRI it's almost insultingly easy: it looks exactly like the fat in the rest of the body, because that's what it is.
Here's the trick that runs this entire page. Fat is bright on T1-weighted images. It's also fairly bright on standard T2. So how do you prove a bright thing is fat and not, say, a pool of blood or a cyst? You suppress it. On a fat-suppressed sequence, real fat goes dark — it gets "turned off." If your bright mass obediently turns black the moment you suppress fat, you've caught it red-handed: it's fat.
A simple lipoma follows fat on every sequence: bright on T1, and it drops out (goes dark) on fat-suppressed images. If it behaves like the subcutaneous fat next door on all sequences, it's almost certainly a lipoma.
When the fat stops being innocent
Pure fat is great. The problem is the in-between lesions — the ones that are mostly fat but have suspicious roommates. Radiologists watch for a few specific tattletales inside an otherwise fatty mass:
- Thick or nodular septa — fat is fine, but fat divided up by chunky internal walls is less fine.
- Non-fatty nodules — areas that don't suppress with the fat, meaning some other tissue is in there.
- Enhancement — solid parts that light up after contrast, telling you there's living, blood-supplied tumor, not just bland fat.
- Big and deep — large size and a location underneath the muscle fascia both raise the stakes.
These are the features that nudge a fatty lump from "lipoma, ignore it" toward "atypical fatty tumor / well-differentiated liposarcoma — get this looked at by someone who does this for a living." The exact line between an atypical lipomatous tumor and a low-grade liposarcoma is genuinely a gray zone in the field, so the honest read is often "fat-containing mass with worrisome features" plus a recommendation, not a swaggering final answer.
"It's mostly fat" is not the same as "it's a lipoma." A well-differentiated liposarcoma can look very fatty and still be malignant. The thick septa, the non-suppressing nodules, and the enhancing soft tissue are the details that separate them — so don't let a lot of fat lull you into skipping the careful look.
The one you can't miss: sarcoma
A soft-tissue sarcoma is the rare malignant tumor that comes from the body's connective tissues — fat, muscle, nerve, vessel, and friends. They're uncommon, but missing one is the nightmare scenario, so we keep a low threshold for taking a mass seriously.
The features that make a radiologist sit up straighter are the ones that scream "this is not normal tissue":
| Feature | Reassuring (think benign) | Worrying (think malignant) |
|---|---|---|
| Size | Small | Large |
| Depth | Superficial, in the fat | Deep, below the fascia |
| Margins | Sharp, well-defined | Infiltrative, messy edges |
| Internal signal | Uniform | Heterogeneous, mixed signal |
| Enhancement | Little or none | Avid, often patchy |
None of these alone seals the deal — plenty of benign things are big, and some sarcomas behave deceptively. But the combination of large, deep, heterogeneous, and enhancing is the classic profile that earns a tissue diagnosis.
A truly aggressive soft-tissue mass and an infection or hematoma can look alarmingly similar on a single sequence. The history (recent trauma, fever, a known bleeding risk) and the full set of sequences matter — don't diagnose a sarcoma, or dismiss one, off one picture.
Why the surgeon needs us first
Here's the part that makes soft-tissue tumors more than an academic puzzle. If a mass might be a sarcoma, the order of operations matters enormously. An ill-planned "let's just shell it out" surgery at the local clinic can contaminate tissue planes, leave tumor behind, and turn a limb-sparing operation into a much bigger one later.
So the management rule is almost absurdly simple to state: a potential sarcoma gets imaged properly, then sent to a sarcoma center for a planned biopsy and treatment — before anyone takes a knife to it. The radiologist who flags "this isn't a simple lipoma" is often the reason that whole chain starts on the right foot.
The most valuable sentence you can write about a soft-tissue mass isn't always a confident diagnosis — it's "features are indeterminate / concerning; recommend evaluation at a sarcoma center prior to resection." That one line protects the patient's limb.
If you remember nothing else: ask whether the lump follows fat. If it's pure, uniform, suppressing fat, exhale. If it's fatty-but-complicated, or big-deep-heterogeneous-and-enhancing, stop trying to be a hero and get the right people involved. Most lumps are nothing. Your job is the handful that aren't. For the bony cousins of these tumors, the same "aggressive features" instinct carries over to bone tumors.